1. Home
  2. ICCT vs LGVN Comparison

ICCT vs LGVN Comparison

Compare ICCT & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCT
  • LGVN
  • Stock Information
  • Founded
  • ICCT 1992
  • LGVN 2014
  • Country
  • ICCT United States
  • LGVN United States
  • Employees
  • ICCT N/A
  • LGVN N/A
  • Industry
  • ICCT Computer Software: Prepackaged Software
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • ICCT Technology
  • LGVN Health Care
  • Exchange
  • ICCT Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • ICCT 9.1M
  • LGVN 31.2M
  • IPO Year
  • ICCT N/A
  • LGVN 2021
  • Fundamental
  • Price
  • ICCT $0.77
  • LGVN $3.29
  • Analyst Decision
  • ICCT
  • LGVN Strong Buy
  • Analyst Count
  • ICCT 0
  • LGVN 1
  • Target Price
  • ICCT N/A
  • LGVN $12.00
  • AVG Volume (30 Days)
  • ICCT 25.7K
  • LGVN 11.1M
  • Earning Date
  • ICCT 08-08-2024
  • LGVN 08-09-2024
  • Dividend Yield
  • ICCT N/A
  • LGVN N/A
  • EPS Growth
  • ICCT N/A
  • LGVN N/A
  • EPS
  • ICCT N/A
  • LGVN N/A
  • Revenue
  • ICCT $9,034,579.00
  • LGVN $978,000.00
  • Revenue This Year
  • ICCT N/A
  • LGVN $137.24
  • Revenue Next Year
  • ICCT N/A
  • LGVN $50.77
  • P/E Ratio
  • ICCT N/A
  • LGVN N/A
  • Revenue Growth
  • ICCT 16.06
  • LGVN N/A
  • 52 Week Low
  • ICCT $0.76
  • LGVN $0.77
  • 52 Week High
  • ICCT $10.60
  • LGVN $35.60
  • Technical
  • Relative Strength Index (RSI)
  • ICCT 36.10
  • LGVN 56.11
  • Support Level
  • ICCT $0.81
  • LGVN $3.36
  • Resistance Level
  • ICCT $0.90
  • LGVN $4.88
  • Average True Range (ATR)
  • ICCT 0.06
  • LGVN 0.69
  • MACD
  • ICCT -0.00
  • LGVN 0.06
  • Stochastic Oscillator
  • ICCT 7.48
  • LGVN 37.04

About ICCT iCoreConnect Inc. Common stock

iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: